Figure 3 Mendelian randomization (MR) using a genetic

Slides:



Advertisements
Similar presentations
C Reactive Protein Coronary Heart Disease Genetics Collaboration BMJ 2011;342:d548.
Advertisements

Interleukin 6 pathway and coronary heart disease
Date of download: 5/27/2016 Copyright © The American College of Cardiology. All rights reserved. From: Causal Assessment of Serum Urate Levels in Cardiometabolic.
Date of download: 9/19/2016 Copyright © The American College of Cardiology. All rights reserved. From: Effect of Naturally Random Allocation to Lower Low-Density.
Mendelian Randomization
A review of low-density lipoprotein cholesterol, treatment strategies, and its impact on cardiovascular disease morbidity and mortality  Rishi K. Wadhera,
Introduction to Direct-to-Consumer Genetic Testing
Nat. Rev. Cardiol. doi: /nrcardio
Baseline Characteristics of Women and Men in Whom Coronary Heart Disease Developed during Follow-up and Matched Controls - A Jennifer K. Pai et al. N.
Cardiometabolic effects of genetic upregulation of the interleukin 1 receptor antagonist: a Mendelian randomisation analysis    The Lancet Diabetes &
Nat. Rev. Cardiol. doi: /nrcardio
Figure 7 Mendelian randomization of overlapping exposures
Nat. Rev. Cardiol. doi: /nrcardio
Figure 3 Metabolism pathway of antiplatelet agents
Figure 2 Different manifestations of myocardial ischaemia
Figure 1 Newly discovered mechanistic pathways
Figure 1 Mendelian randomization study
Nat. Rev. Cardiol. doi: /nrcardio
Figure 4 BMI and mortality in patients with heart failure
Nat. Rev. Clin. Oncol. doi: /nrclinonc
Figure 1 Energy supply–demand matching in health and heart failure
Nat. Rev. Cardiol. doi: /nrcardio
Figure 3 Global rates of sodium, fruit, and vegetable intake
Cardiometabolic effects of genetic upregulation of the interleukin 1 receptor antagonist: a Mendelian randomisation analysis    The Lancet Diabetes &
Nat. Rev. Cardiol. doi: /nrcardio
Figure 2 Three-year survival rates on the basis of body composition
A review of low-density lipoprotein cholesterol, treatment strategies, and its impact on cardiovascular disease morbidity and mortality  Rishi K. Wadhera,
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio
Figure 6 Pharmacodynamic profile of switching between clopidogrel and ticagrelor therapy: results from the RESPOND study Figure 6| Pharmacodynamic profile.
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio
Figure 1 Cardiovascular risk and disease across the life-course
Jonathan C. Cohen, PhD  Journal of Clinical Lipidology 
Figure 1 Decision tree integrating the assessment,
Figure 2 Global cost of HF per capita in 2012
APOC3, Coronary Disease, and Complexities of Mendelian Randomization
Nat. Rev. Cardiol. doi: /nrcardio
Figure 3 Challenges for big data applications in cardiovascular care
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio
Figure 5 Mendelian randomization of biomarkers on the same pathway
Figure 2 Association between coronary artery disease polygenic risk score and the presence of migraine Results are given as odds ratios with 95% confidence.
Figure 2 Absolute difference in seasonal peak
Challenges in Interpreting Multivariable Mendelian Randomization: Might “Good Cholesterol” Be Good After All?  Michael V. Holmes, George Davey Smith 
Elliott P, et al. JAMA 2009;302:37-48.
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Neurol. doi: /nrneurol
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio
Figure 2 Impaired mitochondrial capacity and function in heart failure
Nat. Rev. Cardiol. doi: /nrcardio
Volume 379, Issue 9822, Pages (March 2012)
Nat. Rev. Cardiol. doi: /nrcardio
Nat. Rev. Cardiol. doi: /nrcardio
Adam R. Wende et al. BTS 2017;2: Perturbations in Amino Acid Metabolism During Heart Failure During heart failure, intracardiac branched chain amino.
Balancing Act: Maintaining Amino Acid Levels in the Autistic Brain
Baseline Characteristics of the Subjects*
Nat. Rev. Cardiol. doi: /nrcardio
Figure 2 Ribosome profiling reveals translation of truncating alleles
Baseline characteristics of the 1,842 men without coronary heart disease and the 230 men with a first coronary heart disease event during the 13-year.
Schematic representation of an MR analysis.
Schematic describing metabolism of selected amino acids and the related production of metabolic stimulus-secretion coupling factors involved in insulin.
Mendelian Randomization (Using genes to tell us about the environment)
Figure 2 Metabolic shift in heart failure
Figure 1. Schematic diagram of MR analysis to estimate expected association for genotypes (SNPs) with the trait of insulin resistance. The underlying assumption.
Mendelian Randomization: Genes as Instrumental Variables
Presentation transcript:

Figure 3 Mendelian randomization (MR) using a genetic variant that associates with multiple biomarkers on separate pathways Figure 3 | Mendelian randomization (MR) using a genetic variant that associates with multiple biomarkers on separate pathways. a | Using single nucleotide polymorphisms (SNPs) in PPM1K (which encodes a mitochondrial phosphatase that activates branched-chain α-keto acid dehydrogenase [BCKD], responsible for the rate-limiting step of metabolism of the branched-chain amino acids) to infer causality of three separate amino acids yields an erroneous conclusion, as this inference ascribes a causal estimate to each amino acid from the same PPM1K–diabetes association that is scaled to the PPM1K–amino acid estimate (Table 2). The three amino acids are initially catabolized prior to the enzymatic action of BCKD. b | Using SNPs in APOE to infer causality of C-reactive protein (CRP) yields an erroneous conclusion, as the SNP is pleiotropic for CRP and LDL cholesterol (LDL-C). These figures are schematic representations and should not be interpreted as formal directed acyclic graphs. CHD, coronary heart disease. Holmes, M. V. et al. (2017) Mendelian randomization in cardiometabolic disease: challenges in evaluating causality Nat. Rev. Cardiol. doi:10.1038/nrcardio.2017.78